🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 30048L104 (prev. 64066G101 )
- Market Cap
- Small Cap · $238 Million
- IPO
- 11/19/2014 · $14.00/share
- Previous Symbol
- NEOT (changed 1/18/2018)
- Previous Name
- Neothetics, Inc.
Business: Evofem Biosciences, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. vofem Biosciences aims to advance the lives of women by developing innovative solutions, such as woman-controlled contraception and potential protection from certain sexually transmitted infections (STIs).
Notes: Jan. 17, 2018 -- Evofem Biosciences, Inc. (NASDAQ: EVFM), today announced the closing of the previously announced merger with Neothetics, Inc. (NASDAQ: NEOT). The merged company will operate as Evofem Biosciences, Inc. and will focus on the continued development and commercialization of women's healthcare products. The company will be led by the current Evofem management team under the leadership of Saundra Pelletier, Chief Executive Officer. The stock will trade on the Nasdaq Capital Market beginning on Thursday, January 18, 2018 under the ticker symbol "EVFM" and was assigned a new CUSIP number 30048L104.
Company Contact
- CEO
- Saundra Pelletier
- CFO
- Jay File
- Headquarters
- 12400 High Bluff Drive, Suite 600, San Diego, CA 92130
- Phone
- 858-550-1900
- Investor Relations
- Amy Raskopf · 858-550-1900 · araskopf@evofem.com